Collection 會議論文/會議摘要 [6/9] 期刊論文 [39/39] Siblings 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] Community Statistics 近3年內發表的文件:21(43.75%) 含全文筆數:45(93.75%) 文件下載次數統計 下載大於0次:45(100.00%) 下載大於100次:37(82.22%) 檔案下載總次數:11330(0.21%) 最後更新時間: 2024-11-28 13:30 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 DKK1 as a chemoresistant protein mo... Comprehensive genomic profiling and... Predictive value of FCGBP expressio... Epstein-barr virus BRLF1 induces PD... Germline mutations of homologous re... The prognostic role of LAG-3 expres... Topical antibiotic prophylaxis for ... Phase 1 studies of D07001-F4 and D0... The emergence of RAS mutations in p... Dual role of sprouty2 as an inhibit...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 48. (共2頁) 1 2 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2024-09-27	DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancer	Oncogenesis. 2024 Sep 27;13:Article number 34.
2024-06-19	Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer	Cancer Medicine. 2024 Jun 19;13(12).
2024-05-03	Predictive value of FCGBP expression for treatment response and survival in rectal cancer patients undergoing chemoradiotherapy	Aging. 2024 May 03;16(9):7889-7901.
2024-03-15	Epstein-barr virus BRLF1 induces PD-L1 expression in nasopharyngeal carcinoma cells	Viral Immunology. 2024 Mar 15;37(2):115-123.
2024-02-13	Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan	Journal of Biomedical Science. 2024 Feb 13;31:Article number 21.
2024-02	Topical antibiotic prophylaxis for preventing surgical site onfections of clean wounds: A systematic review and meta-analysis	Surgical Infections. 2024 Feb;25(1):32-38.
2023-11	The prognostic role of LAG-3 expression in metastatic colorectal cancer	Annals of Oncology. 2023 Nov;34(Suppl. 4):S1514-S1515.
2023-10	The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: A noninterventional, uncontrolled multicenter study	British Journal of Cancer. 2023 Oct;129(6):947-955.
2023-07	Dual role of sprouty2 as an inhibitor of RAS/ERK-driven proliferation and a promoter of cancer invasion in KRAS wild-type colorectal cancer	Molecular Carcinogenesis. 2023 Jul;62(7):951-962.
2023-06	Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors	Journal of Clinical Oncology. 2023 Jun;41(16, Suppl.):Meeting Abstract 3148.
2023-03	HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study	European Journal of Cancer. 2023 Mar;181:62-69.
2023-02-03	MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition	Journal of Experimental and Clinical Cancer Research. 2023 Feb 3;42:Article number 40.
2023-01-30	Real-world effectiveness of sorafenib versus lenvatinib combined with PD-1 inhibitors in unresectable hepatocellular carcinoma	Cancers. 2023 Jan 30;15(3):Article number 854.
2022-11	CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer	British Journal of Cancer. 2022 Nov;127(9):1615-1628.
2022-11	BEAR study: A single-arm, phase II trial of BI-754091 and afatinib for refractory esophageal squamous cell carcinoma	Annals of Oncology. 2022 Nov;33(Suppl. 9):S1472-S1473.
2022-10-31	PD-L1 expression in high-risk early-stage colorectal cancer-its clinical and biological significance in immune microenvironment	International Journal of Molecular Sciences. 2022 Oct 31;23(21):Article number 13277.
2022-10-23	Real-world comparative effectiveness of nivolumab versus pembrolizumab in patients with unresectable hepatocellular carcinoma	Pharmaceutics. 2022 Oct 23;14(11):Article number 2263.
2022-07-13	SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma	Journal of Experimental and Clinical Cancer Research. 2022 Jul 13;41:Article number 220.
2022-06	Role of high ubiquitin-conjugating enzyme E2 expression as a prognostic factor in nasopharyngeal carcinoma	Oncology Letters. 2022 Jun;23(6):Article number 194.
2022-02-01	A prediction model for tumor recurrence in stage II–III colorectal cancer patients: From a machine learning model to genomic profiling	Biomedicines. 2022 Feb 1;10(2):Article number 340.
2022-02	Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors	Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660.
2021-12-08	Association between altered oncogenic signaling pathways and overall survival of patients with metastatic colorectal cancer	Diagnostics. 2021 Dec 8;11(12):Article number 2308.
2021-10-19	SOD2 enhancement by long-term inhibition of the pi3k pathway confers multi-drug resistance and enhanced tumor-initiating features in head and neck cancer	International Journal of Molecular Sciences. 2021 Oct 19;22(20):Article number 11260.
2021-07-05	Age as a modifier of the effects of chemoradiotherapy with infusional 5-fluorouracil after D2 dissection in gastric cancer	Aging. 2021 Jul 5;13(13):17337-17348.
2021-06-12	Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers	Oncoimmunology. 2021 Jun 12;10(1):Article number 1943253.

顯示項目1-25 / 48. (共2頁) 1 2 > >> 每頁顯示[10|25|50]項目